CSF1R is a receptor tyrosine kinase that mediates tumorigenesis in tumor-immune microenvironments and is expressed on tumor-associated macrophages (TAMs) [8,9,10]; the high expression levels of CSF1R correlate with poor survival in patients with various malignancies [8,9,10,11]. This evidence concerns the gene NTRK1 and neoplasm.